We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
JCVI position statement on the use of meningococcal B (MenB) vaccine in the UK.
An interim position statement about the use of Bexsero meningococcal B vaccine in the UK released by JCVI.
Statements from the Joint Committee on Vaccination and Immunisation (JCVI) about use of Bexsero® meningococcal B vaccine in the UK.
Paper prepared by the COVID-19 Clinical Information Network (CO-CIN).
The Joint Committee on Vaccination and Immunisation (JCVI) is today advising that all 16 and 17 year olds receive their first dose of the Pfizer-BioNTech vaccine.
First published during the 2019 to 2022 Johnson Conservative government
The JCVI has advised that pregnant women should be offered the COVID-19 vaccine at the same time as the rest of the population, based on their age and clinical risk group.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).